Merck (MRK 0.49%), a hefty dividend stock and one of the world's largest drugmakers, may seem like a stagnant big pharma to many investors -- but does the company still have room to grow? In this video, health care analyst Max Macaluso outlines some of the biggest opportunities that can drive Merck's growth in 2013 and beyond.
What Will Drive Merck's Growth in 2013?
By Max Macaluso – Jan 25, 2013 at 6:30PM
NYSE: MRK
Merck
Market Cap
$219B
Today's Change
(-0.49%) $0.43
Current Price
$87.18
Price as of October 23, 2025 at 4:00 PM ET
Does this big pharma have more opportunities ahead?
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo